Summary Exogenous purines () 10-SM) can modulate the cytotoxicity of methotrexate (MTX) in cultured cells, protecting cells at low MTX concentrations (S 8 x 10-8M) and markedly potentiating its effect at higher concentrations. The ability of hypoxanthine (HX) 
Biochemical studies have traditionally focused on the role of methotrexate (MTX) as an inhibitor of the dihydrofolate reductase (DHFR) enzyme, causing a depletion of the reduced folate pool and subsequent inhibition of thymidylate synthesis (Cadman, 1983) . However, the polyglutamylated forms of MTX have also been found to be potent inhibitors of some other folate-dependent enzymes involved in purine synthesis and folate conversions (Allegra et al., 1984) . The sites of action of MTX and its polyglutamylate derivatives on purine and thymidylate synthesis are illustrated in Figure 1 .
Exogenous purines only rescued cultured cells from the cytotoxic effects of low concentrations (below 8 x 10-8M) of MTX. At higher MTX concentrations, exogenous purines markedly potentiated the cytotoxicity of MTX (Taylor et al., 1982) . The purines were thought to either increase the cytotoxicity of MTX (Borsa & Whitemore, 1969; Fairchild et al., 1988) or else become toxic in themselves (Taylor et al., 1982; Yoshioka et al., 1987a) . Recent studies have reported that MTX treated NIH/3T3 cells accumulated singlestranded and double-stranded DNA breaks preceding cell death and that the DNA damage was prevented by the inhibition of protein synthesis by cycloheximide (Lorico et al., 1988) . DNA extracted from MTX treated HL-60 cells and electrophoresed on an agarose gel has been reported to be fragmented into multimers of approximately 200 base pairs (bp) (Kaufmann, 1989) . This is a characteristic biochemical marker for a mode of cell death known as apoptosis or programmed cell death (Wyllie et al., 1984) .
In this study, we compared the effects of HX on the cytotoxicity of two non-classical antifolates with MTX in murine leukaemic L1210 cells. Hx (10-4 M) was used because it was reported to be the highest non-toxic concentration which elicited the maximum potentiation of MTX cytotoxicity in L1210 cells (Taylor et al., 1982) . Piritrexim (PTX) is a small lipid soluble diaminopyrido-pyrimidine inhibitor of DHFR (Figure 1 ) which is not polyglutamylated in cells (Duch et al., 1982) . ICI 198583 (2-desamino-2-methyl-10-propagyl-5,8-dideazafolic acid) is a quinazoline-based inhibitor of thymidylate synthetase (Figure 1 ) and is the 2-desamino, 7-methyl derivative of the prototype drug, N'l- C02, 5% 02 atmosphere and the wells were inspected for positive colonies after 14 days. The cloning efficiency of the cells was calculated from the proportion of negative wells using Poisson statistics and x2 minimisation (Taswell, 1981) .
Cloning results were expressed as colony forming units The DNA in the precipitate was hydrolysed by heating to 90°C for 10 min in 80 ml 5% TCA and quantified using a modification of the diphenylamine method (Sellins & Cohen, 1987) . The degree of DNA fragmentation refers to the percentage of DNA in the 13000 g supernatant divided by the total DNA from the pellet and supernatant.
Ribonucleotide pool assay
Approximately 1 x 108 cells were washed twice in cold PBS and extracted with cold 0.6 M perchloric acid (Kemp et al., 1986) . The neutralised extracts were subjected to HPLC analysis (Sant et al., 1989) to determine the relative quantity of purine and pyrimidine nucleotides. The eluted metabolites were monitored by an LK2140 rapid spectral detector connected to an IBM XT microcomputor (Sant et al., 1989; Lyons & Christopherson, 1990 ). The area under each peak was calculated using the Nelson Analytical 3000 series chromatography data system (Version 5.0). The results were expressed as percentage area of the untreated control (derived from the mean of the 0, 6 and 12 h samples).
Deoxyribonucleoside triphosphate pool assay A total of 5 x 106 viable cells were washed once in cold PBS (with 2 mM EDTA) and extracted with ice cold 60% ethanol. The extract was lyophilised and resuspended in 500 ml of 10 mM Tris buffer (pH 7.85). The sample was then centrifuged at 11000 g for 15 min at 4°C and the supernatants stored at -20°C. The deoxyribonucleotides were measured by a modification of the DNA polymerase assay (Mann & Fox, 1986) . The concentrations of the deoxyribonucleoside triphosphates were determined from calibration curves of picomole amounts of pure standards.
Results
A microtitration cloning assay was used to determine the effects of HX on MTX and the results shown in Figure 2a are similar to those using a soft agar cloning assay (Taylor et al., 1982) . Using the same microtitration assay two other antifolates, PTX and ICI 198583 were also tested. The effects of 24 h exposure to ICI 198583 (the inhibitor of thymidylate synthetase) in the presence or absence of exogenous HX is shown in Figure 2b . For the three different concentrations of the drug used (10-7, 10-6 and 10-5M), the addition of 10-4M HX had no significant effect on the cytotoxicity of ICI 198583. On the other hand, when PTX (an inhibitor of DHFR) was used, there was a marked potentiation of (0) cytotoxicity at concentrations at or greater than 10-7M. There was no protection at a lower drug concentration (10-8M) as shown in Figure 2c .
Electrophoretic analysis of DNA extracted from untreated and drug-treated cells is shown in Figure 3 The degree of DNA fragmentation was determined by separating the cleaved DNA from the intact chromatin by centrifugation and measuring the amount of DNA present in the supernatant and pellet using the diphenylamine method (Sellins & Cohen, 1987) . The degree of DNA fragmentation refers to the ratio of DNA in the supernatant to the total DNA in the supernatant and pellet. The degree of DNA fragmentation in the untreated control and in cells exposed to the antifolates for 24 h is shown in Figure 4 . The background fragmentation in the untreated control was approximately 5%. The addition of 10-4M HX alone did not significantly (P> 0.5; Student's t-test) increase the degree of fragmentation. However, when 10-5M MTX or PTX was added together with HX, there was a 20% (P<0.01) increase in fragmentation. This was associated with the potentiation of the cytotoxicity of MTX and PTX by HX ( Figure  2a and c) . In contrast, the addition of HX with 10-5M ICI 198583 made little difference (3%) to the degree of fragmentation compared with ICI 198583 alone. This finding is in agreement with the lack of potentiation of ICI 198583 cytotoxicity by HX (Figure 2b) .
To explore the possible biochemical mechanisms underlying purine potentiation, the perturbations of the ribonucleotide and deoxyribonucleoside triphosphate pools were measured in cells treated with 10-5M MTX or ICI 198583 in the absence or presence of 10-4M HX.
Since MTX depletes folate pools and its polyglutamylated derivatives inhibit specific enzymes involved in the purine synthesis pathway, the pools of the four ribonucleotides (ATP, GTP, CTP and UTP) as well as two purine intermediates (SAICAR and IMP) were measured over a 24h period following the addition of the drugs. As shown in Figure 5a , 10-5M MTX extent as shown in Figure 6a and b. HX by itself caused minor perturbations in dATP (111 ± 1.47% (mean ± s.d.) and dTTP (79 ± 11%) after 12 h exposure.
Discussion
The cytotoxicity of MTX has been shown to be modulated by the presence of exogenous purines (Taylor et al., 1982) . This study compares the ability of a preformed purine (hypoxanthine) to modulate the cytotoxicity of two other antifolates: PTX, an inhibitor of DHFR which is not polyglutamylated in cells (Duch et al., 1982) and ICI 198583, a potent inhibitor of thymidylate synthetase (Hughes et al., 1988; Jackman et al., 1988; .
Using a microtitration cloning assay, 10-5M ICI 198583 was found to be more toxic (reducing the number of c.f.u. ml-' to 0.02% of the untreated control) than 10-SM MTX (1.1%) or 10-5M PTX (0.6%). The addition of 100mM HX potentiated the cytotoxicity of the two inhibitors of DHFR (MTX and PTX), increasing their cytotoxicity to the same level as ICI 198583 alone. This potentiation of the cytotoxicity of the DHFR inhibitors by HX was also observed in cells treated with metoprine, a lipophilic inhibitor of DHFR (data not shown). As with ICI 198583, HX did not affect the cytotoxicity of another thymidylate synthetase inhibitor, 5-fluorodeoxyuridine (FUdR) (data not shown).
Two hypotheses may explain the purine potentiation of the DHFR inhibitors. Firstly, Fairchild et al. (1988) , after performing tritiated uridine uptake and cell cycle studies, concluded that the potentiation of MTX cytotoxicity in L1210 cells by HX was due to the restoration of normal RNA synthesis, which allowed cells to progress onto the more lethal S phase. That is, HX increases the number of cells susceptible to the cytotoxic mechanisms of MTX. This may involve dUTP incorporation into DNA during genomic replication and subsequent single-stranded breaks in the DNA (Goulian et al., 1980) . However, measurements of RNA and DNA contents of CCRF-CEM (F2) cells treated with 0.1 mM MTX have shown that while HX allowed continued RNA synthesis, the block in cell cycle progression was only overcome by the addition of thymidine and HX (Taylor & Tattersall, 1981) . This inability of HX to alleviate the block was also demonstrated in other cell lines (Sen et al., 1990) .
The other hypothesis is that the purines may become toxic themselves. This is based on a study of cytotoxicity involving a series of preformed purines in conjunction with MTX. There was a strong relationship between the extent of purine potentiation of MTX and their effects on the dATP pools (Taylor et al., 1982) . The link between cytotoxicity and an increase in dATP pool may be due to several mechanisms. A rise in dATP pool has been shown to inhibit DNA repair of single-stranded DNA breaks in resting lymphocytes either by blocking ribonucleotide reductase (which inhibits de novo dNTP synthesis) or DNA ligation (Meuth, 1989; Seto et al., 1986) . Moreover, dNTP pool balance is essential for fidelity in DNA synthesis in dividing cells (Yoshioka et al., 1987b) . Inhibition of either DNA repair or synthesis is sufficient to cause cell death (Yoshioka et al., 1987a) .
The observed differences in dATP pool perturbations ( Figure 6 ) between MTX, a DHFR inhibitor and ICI 198583, a thymidylate synthetase inhibitor, may be explained by the following model. The DHFR inhibitors strongly inhibit de novo purine synthesis either by lowering the reduced folate cofactor pools or by direct inhibition of the enzymes involved in purine synthesis (Figure 1) . This results in a rise in phosphoribosylprophosphate (PRPP) levels (Cadman, 1979) and exogenous HX or other purines can be quickly metabolised to raise the purine ribonucleotide ( Figure Sb) levels. In cells treated with MTX and HX, the synthesis of dTTP was inhibited (Figure 6a) . During S phase, excess dATP would accumulate due to lack of complementary dTTP nucleotides, resulting in an elevation of the dATP pool (Figure 6a ). On the other hand ICI 198583 stimulates de novo synthesis ( Figure Se) , possibly by inhibiting thymidylate synthetase and sparing the reduced folates for purine synthesis. This may be sufficient to cause the three-fold increase in dATP pools, with or without added HX. This mechanism would explain the observations of an experiment which involved the use of synchronised FM3A cells treated with FUdR. The drug resulted in an elevation of the dATP pool and cell death only if it was added during S phase. When the drug was added after S phase, when DNA synthesis was completed, the dATP pool remained unaffected until the cells cycled to the next S phase where the dATP pool was elevated by 240% and followed by cell death (Yoshioka et al.,1987b) .
A previous report has shown that MTX treated HL-60 cells die via a regulated process known as apoptosis (Kaufmann, 1989) . Apoptosis also requires protein synthesis and is characterised by the activation of an endonuclease which cleaves DNA at the internucleosomal linker regions producing fragments of approximately 200 bp multimers (Wyllie et al., 1984) . A study using a rat prostatic cancer cell line showed that FUdR clearly resulted in the cleavage of the DNA into 200 bp multimers (Kyprianou & Issacs, 1989) . DNA extracted from L1210 cells treated with 10-5M MTX, PTX or ICI 198583 for 24 h was also fragmented into the characteristic multimers of 200 bp, indicating that antifolate treated cells die via apoptosis. The degree of DNA fragmentation was increased significantly by 20% when HX was added with MTX or PTX, but only by 3% with ICI 198583 treatment. This correlation between DNA fragmentation and cytotoxicity suggests that the increase in cytotoxicity may also be via the apoptotic pathway.
We postulate that the addition of HX with MTX allowed an increase in dATP pools during DNA synthesis. This elevation in dATP then serves as a strong signal (in the same manner as ICI 198583) for cells to commit themselves to the apoptotic pathway. Other studies have already shown that an inhibitor of de novo purine synthesis-5,10-dideazatetrahydrofolate (Moran et al., 1985) protected cells from the effects of a thymidylate synthetase inhibitor, CB 3717 (Gallivan et al., 1988) . Further studies on the interactions between these antifolates should clarify whether the elevation of dATP pools is the main cytotoxic mechanism of purine potentiation and perhaps of antifolate treatment per se.
